A nurse is reviewing the medical record of a client who has a history of coronary artery disease. The nurse should identify which of the following as a risk factor? (Click on the "Exhibit" button for additional information about the client. There are three tabs that contain separate categories of data.)

Coronary artery disease (CAD) risk factors include nonmodifiable factors such as age and gender, and modifiable factors such as lipid levels, lifestyle habits, and medication use. Certain medications can increase cardiovascular risk by influencing lipid metabolism, coagulation, or vascular function. In women, hormone therapy is a well-recognized contributor to increased thrombotic and cardiovascular events. Nurses must evaluate all aspects of the patient’s history, including prescribed therapies, when identifying risk factors. Rationale: A. Total cholesterol level is within a desirable range and does not indicate a risk factor in this client. A total cholesterol of 150 mg/dL is considered within normal limits and does not independently increase CAD risk. Risk is more associated with elevated LDL and low HDL rather than total cholesterol alone in this case. B. Diet is not a risk factor in this scenario because the client follows a vegan diet, which is generally associated with lower saturated fat intake and improved cardiovascular outcomes. This dietary pattern is typically considered protective rather than harmful in relation to coronary artery disease. C. Medications are a significant risk factor because the client is taking Conjugated estrogen. Estrogen therapy is associated with increased risk of thromboembolic events and can contribute to cardiovascular complications in certain populations. In a client with existing CAD and anginal symptoms, hormone therapy is considered a modifiable risk factor that may worsen cardiovascular outcomes. D. Supplement use is not identified as a primary risk factor in this case. The client’s use of fish oil supplements is generally associated with potential cardiovascular benefits such as triglyceride reduction. Although supplements should always be reviewed for interactions, they are not the most significant risk factor compared to estrogen therapy in this scenario.